Laparoscopic cholecystectomy only could be an appropriate treatment for selected clinical R0 gallbladder carcinoma

C. M. Kang, G. H. Choi, S. H. Park, K. S. Kim, J. S. Choi, W. J. Lee, B. R. Kim

Research output: Contribution to journalArticlepeer-review

39 Citations (Scopus)


Background: Laparoscopic cholecystectomy (LC) for gallbladder carcinoma still is controversial except for the early stages of gallbladder carcinoma (Tis). This study was designed to evaluate and revisit the role of LC in treating gallbladder carcinoma. Methods: Available medical records of patients with surgeries for gallbladder carcinoma were retrospectively investigated from August 1992 to February 2005. Results: Among 219 patients treated for gallbladder carcinoma, 57 (26%) underwent LC. A total of 16 patients (28.1%) underwent subsequent radical cholecystectomy (LC-RC), and 41 (71.9%) were only followed up without radical surgery (LC). Tis was found in 11 patients (19.3%), T1a in 3 patients (5.3%), T1b in 8 patients (14%), T2 in 19 patients (33.3%), and T3 in 16 patients (28.1%). The findings showed R0 in 14 cases of the radical cholecystectomy group, and clinical R0 was noted in 30 cases of the LC-only group. No survival differences were noted between LC and LC-RC (p = 0.2575), especially in the case of T2 lesions (p = 0.6274), nor between the R0 and clinical R0 (p = 0.5839). However, significant survival differences were noted between the R2 and R0 groups, and between R2 and clinical R0, respectively (p < 0.001). Conclusions: The findings show that LC could be appropriate treatment for gallbladder carcinoma only in selected cases of clinical R0 lesions.

Original languageEnglish
Pages (from-to)1582-1587
Number of pages6
JournalSurgical Endoscopy and Other Interventional Techniques
Issue number9
Publication statusPublished - 2007 Sept

All Science Journal Classification (ASJC) codes

  • Surgery


Dive into the research topics of 'Laparoscopic cholecystectomy only could be an appropriate treatment for selected clinical R0 gallbladder carcinoma'. Together they form a unique fingerprint.

Cite this